CED Cannabis Science Digest: Clinical Evidence on Mental Health and Cannabis
This digest presents cannabis mental health clinical evidence from three July 2026 peer-reviewed papers. It highlights important context on antidepressant co-use, adolescent depression, and high-THC product risk. These findings support educational…
A clinician-led analysis of causation, confounding, and mental health risk interpretation
This cannabis psychosis risk review examines how the 2026 JAMA Internal Medicine paper interprets observational mental health data. The analysis explores confounding, reverse causation, exposure definition problems, and the difference between relative…
Can CBD Gummies Cause Psychosis? – Clinical Insights
CBD gummies psychosis clinical insights highlight the importance of patient screening and product quality. Emerging case reports raise questions about CBD's safety in vulnerable individuals. Clinicians must consider these insights when recommending…
CBD Gummies and Psychosis: What the Evidence Shows for Everyday Use
CBD gummies and psychosis risk remain an area with limited and contradictory evidence. Clinicians must assess psychosis risk carefully when counseling patients using CBD gummies. Understanding the clinical evidence on CBD gummies and psychosis risk is…
Endocannabinoid System Research: Cannabis in Mental Health Care
This article reviews endocannabinoid system cannabis mental health research focusing on clinical trials and digital interventions. It highlights the potential of cannabis in mental health care supported by recent studies. The research explores scalable…
FDA-Approved CBD Drug Shows Early Promise in Anorexia Patients
Emerging research on the FDA approved CBD drug anorexia treatment shows early promise in patients. This study highlights potential benefits in appetite regulation and anxiety reduction. Further clinical trials are needed to confirm efficacy and safety.
So, What Does an Adult at Low Risk of Cannabis Dependence Look Like?
Understanding cannabis adult low risk dependence is essential for safe therapeutic use. Identifying risk factors helps patients and physicians create individualized treatment plans. This knowledge supports safer cannabis use with minimized dependence…
Kaiser Study Reveals Psychiatric Risks of Cannabis in Teens
The adolescent cannabis psychiatric risk data study highlights a doubled risk of psychotic and bipolar disorders in teens using cannabis. This large Kaiser Permanente study followed over 463,000 adolescents and found cannabis use preceded psychiatric…
Takedown of Recent JAMA Cannabis Review
The jama cannabis review is often misinterpreted as a verdict, but it is a nuanced physician analysis of current evidence. This review clarifies what the science shows about cannabis risks and benefits. It emphasizes the need for careful clinical…
Cannabis and Psychosis: 5 Reasons This Study Doesn’t Say What You Think
The cannabis psychosis study Colorado reveals a rise in psychosis hospitalizations linked to cannabis use disorder. However, this increase reflects complex factors beyond cannabis itself. Understanding this study helps clarify the real public health…